Market revenue in 2022 | USD 172.0 million |
Market revenue in 2030 | USD 225.3 million |
Growth rate | 3.4% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.4% in 2022. Horizon Databook has segmented the Italy orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
The country has been severely hit by the pandemic, and several surgeries were postponed as a rapid response to manage it. This hampered market growth. The country’s market is expected to recover during the forecast period.
In April 2021, the Azienda Ospedaliero-Universitaria Consorziale Policlinico in Italy completed a study on Platelet Rich Plasma (PRP) Injections for knee osteoarthritis in adults aged between 40 and 81 years. This study is one of the many R&D projects registered on the clinicaltrials.gov platform of the U.S. National Library of Medicine.
Various factors anticipated to drive market growth in the country are growing number of surgical procedures and increasing elderly population. Market players are undertaking numerous strategies, such as development of new products, expansion strategies, and distribution agreements, to improve penetration of their products.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into Italy orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account